You just read:

FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira

News provided by

Analysts' Corner

Dec 18, 2013, 08:00 ET